Compass Therapeutics Inc. (CMPX): Price and Financial Metrics

Compass Therapeutics Inc. (CMPX): $3.38

0.07 (-2.03%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add CMPX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#108 of 337

in industry

CMPX Price/Volume Stats

Current price $3.38 52-week high $4.08
Prev. close $3.45 52-week low $0.76
Day low $3.37 Volume 608,600
Day high $3.66 Avg. volume 2,260,640
50-day MA $2.25 Dividend yield N/A
200-day MA $1.63 Market Cap 465.05M

CMPX Stock Price Chart Interactive Chart >


Compass Therapeutics Inc. (CMPX) Company Bio


Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.


CMPX Latest News Stream


Event/Time News Detail
Loading, please wait...

CMPX Latest Social Stream


Loading social stream, please wait...

View Full CMPX Social Stream

CMPX Price Returns

1-mo 30.00%
3-mo 150.37%
6-mo 188.89%
1-year 78.84%
3-year 34.13%
5-year N/A
YTD 133.10%
2024 -7.05%
2023 -68.99%
2022 58.68%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!